Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HMGCR | P04035 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | CPT2 | P23786 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | ACLY | P53396 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27342657 | 0.96 | ALDH1A1 (0.53) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL10777495 | 0.87 | ALDH1A1 (0.46) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL9390835 | 0.83 | ALDH1A1 (0.48) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL5394504 | 0.83 | CA4 (0.50) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL11509869 | 0.81 | HMGCR (0.52) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL10938453 | 0.81 | HMGCR (0.60) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL38732 | 0.77 | — | — | |
| SCHEMBL880688 | 0.77 | ALDH1A1 (0.56) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL9858878 | 0.77 | ALDH1A1 (0.56) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL9771853 | 0.74 | ALDH1A1 (0.40) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024136204-A1 | OXYGEN GENERATING FUNCTIONAL COMPOSITION CAPABLE OF LONG-TERM OXYGEN SUPPLY TO CROP CULTIVATION AREAS AND FARMING METHOD USING SAME | 박상진 | 2024-06-27 | — | — | WO | claimed |
| WO-2024128684-A1 | VERSATILE AND PORTABLE OXYGEN GENERATION COMPOSITION, AND USE METHOD USING SAME | 이윤나 | 2024-06-20 | — | — | WO | claimed |
| EP-3160487-B1 | ANTIMICROBIAL COMPOSITIONS FOR THE VETERINARY FIELD | Icf Srl (IT) | 2024-05-01 | — | — | EP | claimed |
| WO-2024033450-A1 | BIOLOGICAL TEST SAMPLING KIT | HEMODX AS (NO) | 2024-02-15 | — | — | WO | claimed |
| EP-3829535-B1 | COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CUTANEOUS AFFECTIONS | Icf Srl (IT) | 2023-11-08 | — | — | EP | claimed |
| EP-3307064-B1 | LONG TERM STORAGE AND PRESERVATION OF PLATELETS | HARVARD COLLEGE (US) | 2023-09-06 | — | — | EP | claimed |
| WO-2023146478-A2 | A CATALYST COMPOSITION | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-08-03 | — | — | WO | claimed |
| EP-3322482-B1 | TOPICAL CIPROFLOXACIN COMPOSITIONS | TAP PHARMACEUTICALS AG (CH) | 2023-07-26 | — | — | EP | claimed |
| WO-2023096800-A1 | ANTICOAGULANT COMPOUNDS COMPRISING CHELATING AGENTS AND CATIONIC ANTI-COAGULATION ENHANCERS AND METHODS AND DEVICES FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2023-06-01 | — | — | WO | claimed |
| CN-115895792-A | Cleaning solution and kit | 上海新阳半导体材料股份有限公司 | 2023-04-04 | — | — | CN | claimed |
| WO-2009026473-A2 | STABILIZED THERAPEUTIC COMPOSITIONS AND FORMULATIONS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2009-02-26 | — | — | WO | claimed |
| EP-1799198-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES CHARACTERIZED BY PATHOLOGICAL CALCIFICATION | Nanobac Life Sciences (US) | 2007-06-27 | — | — | EP | claimed |
| EP-1796683-A1 | METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF CALCIUM CHELATORS, BISPHOSPHONATES AND/OR CITRATE COMPOUNDS AND THEIR PHARMACEUTICAL USES | Nanobac Life Sciences (US) | 2007-06-20 | — | — | EP | claimed |
| US-20070111879-A1 | Zirconia-alumina nano-composite powder and preparation method thereof | LG CHEM, LTD. (KR) | 2007-05-17 | — | — | US | claimed |
| US-20070048296-A1 | Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation | NANOBAC PHARMACEUTICALS, INC. | 2007-03-01 | — | — | US | claimed |
| US-20060083727-A1 | Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation | NANOBAC PHARMACEUTICALS, INC. | 2006-04-20 | — | — | US | claimed |
| US-20060069069-A1 | Methods and compositions for the administration of calcium chelators, bisphosponates and/or citrate compounds and their pharmaceutical uses | NANOBAC PHARMACEUTICALS, INC. | 2006-03-30 | — | — | US | claimed |
| US-20060069068-A1 | Methods and compositions for the treatment of diseases characterized by pathological calcification | NANOBAC PHARMACEUTICALS, INC. | 2006-03-30 | — | — | US | claimed |
| WO-2006019844-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES CHARACTERIZED BY PATHOLOGICAL CALCIFICATION | NANOBAC LIFE SCIENCES (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2006019843-A1 | METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF CALCIUM CHELATORS, BISPHOSPHONATES AND/OR CITRATE COMPOUNDS AND THEIR PHARMACEUTICAL USES | NANOBAC LIFE SCIENCES (US) | 2006-02-23 | — | — | WO | claimed |